Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
about
Flow cytometry-assisted Monte Carlo simulation predicts clonogenic survival of cell populations with lognormal distributions of radiopharmaceuticals and anticancer drugs.Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease.A method to predict response of cell populations to cocktails of chemotherapeutics and radiopharmaceuticals: validation with daunomycin, doxorubicin, and the alpha particle emitter (210)Po.Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines.Molecular and cellular effects of Auger emitters: 2008-2011.Tumour targeting with radiometals for diagnosis and therapy.Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an (125)I-labelled DNA-intercalator.Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.Fast Monte Carlo simulation of DNA damage induction by Auger-electron emission.Nuclisome--targeting the tumor cell nucleus.
P2860
Q33642550-4F33D785-DF24-4FF5-927C-5FB5D3196893Q35854855-5D54C604-384A-40F1-9081-29C928B3E883Q36103417-020ABE83-BDC2-434E-8831-8B6364AA39B0Q37559437-97BCF24A-C08D-4BAC-B504-D9083B3941F6Q38018374-91A33699-C757-440C-85E1-23B7D30D1EEDQ38100112-E61FDC85-0164-4A17-AB20-03CE8724F494Q39013381-F6375FDE-957C-4F0A-8E8A-A3B5295F0838Q39520783-54E15B2D-8F81-407C-BAD1-4E68D618DE2DQ42575184-91043731-4A8C-4065-A79D-A5EF6718F04EQ44291413-2EBB70FE-B00A-4747-A6E6-97DD6B598DACQ54532261-F5C8E81C-86F3-4EC4-8EDE-C2776171776F
P2860
Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Methotrexate, paclitaxel, and ...... agent (111)In-NLS-trastuzumab.
@en
Methotrexate, paclitaxel, and ...... agent (111)In-NLS-trastuzumab.
@nl
type
label
Methotrexate, paclitaxel, and ...... agent (111)In-NLS-trastuzumab.
@en
Methotrexate, paclitaxel, and ...... agent (111)In-NLS-trastuzumab.
@nl
prefLabel
Methotrexate, paclitaxel, and ...... agent (111)In-NLS-trastuzumab.
@en
Methotrexate, paclitaxel, and ...... agent (111)In-NLS-trastuzumab.
@nl
P2093
P1476
Methotrexate, paclitaxel, and ...... agent (111)In-NLS-trastuzumab.
@en
P2093
Daniela F Villani
Danny L Costantini
Raymond M Reilly
P304
P356
10.2967/JNUMED.109.069716
P407
P577
2010-02-11T00:00:00Z